How AI is shaping veterinary hematology

This content is sponsored by Zoetis

Veterinary diagnostics are evolving rapidly, and nowhere is this more evident than in the field of hematology. As clinics face increasing demands for speed, accuracy, and efficiency, the integration of artificial intelligence (AI) into diagnostic tools is transforming how veterinarians approach blood analysis.

Austin Viall, DVM, DACVP, associate professor of clinical pathology at the University of California Davis, has observed significant advancements in in-clinic CBC analyzers over the past 15 years. Recent developments have brought microscopy and dye-based methods, once exclusive to reference laboratories, into the hands of in-clinic practitioners, enhancing diagnostic capabilities at the point of care.

One of the most promising innovations in this space is Zoetis’ Vetscan OptiCell™, a next-generation hematology analyzer powered by AI. Designed to deliver rapid, reliable Complete Blood Count (CBC) results, Vetscan OptiCell enables veterinary professionals to identify blood cell abnormalities within minutes, supporting faster clinical decision-making and helping to improve patient care.

AI in tools such as Vetscan OptiCell functions as a powerful assistant to veterinary healthcare teams, generating reliable results that will help complete the clinical status of the patient and with seamless integration to practice management software.¹

This supportive technology does not replace veterinary expertise but – importantly – amplifies it. When used correctly, AI enhances diagnostic capabilities, treatment planning, and medication prescription while allowing the clinician to make the final decision on patient care. As AI continues to evolve, the need for continuous training and education about its potential uses and limitations is vital.

Staffing shortages and burnout could also be relieved with AI’s ability to pick up more of the repetitive tasks, allowing veterinary teams to focus more on patient interaction and complex case management. This efficiency is especially valuable in busy practices where time and resources are limited.

Expanding the Zoetis diagnostics portfolio

In addition to the Vetscan OptiCell analyzer, Zoetis is pushing the boundaries of veterinary diagnostics with its Vetscan Imagyst® platform. The promise of Vetscan Imagyst was continuous innovation, and the company has delivered, with the most recent introduction of AI Masses. The latest indication enhances Zoetis’ cytology offering by enabling fast, accurate^2,3 AI analysis of lymph node and skin/subcutaneous masses, delivering results in minutes. Now with a total of seven unique testing applications, this makes Vetscan Imagyst the world’s most capable veterinary artificial intelligence (AI) analyzer.^*

The platform’s cloud-based architecture also enables remote consultations and second opinions, fostering collaboration between general practitioners and specialists. This connectivity ensures that even smaller or rural clinics can access advanced diagnostic insights without needing to send samples off-site.

What’s next?

While AI-driven diagnostics are still evolving, the potential for the technology is immense. As adoption grows, these innovations will not only improve operational efficiency but also elevate the standard of care, making advanced diagnostics more accessible to veterinary practices of all sizes.

The future of veterinary medicine lies in leveraging technology to support veterinarians in their mission to provide high-quality care, helping them navigate today’s challenges while preparing for tomorrow’s demands. With AI-driven diagnostics at the forefront, the future of veterinary medicine is brighter than ever.

For more information, visit www.zoetisdiagnostics.com.

References

1. Zoetis Data on File. Study Report - DHXMZ-US-24-235
2. Zoetis Data on File. Study Report - DHXMZ-US-25-285
3. Zoetis Data on File. Study Report - DHXMZ-US-25-286

^*Vetscan Imagyst is the only commercially available analyzer on the market offering seven testing capabilities

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2025 Zoetis Services LLC. All rights reserved.